26 Oct

Covid-19 patent disputes highlight safe harbour uncertainties for research tool innovators

Lawsuits filed by Allele Therapeutics against Pfizer and Regeneron will not only determine the distribution of covid-related revenues, but could also have big implications for research tool innovators

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth